CHUGAI PHARMACEUTICAL CO., LTD.
中外製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4519
FY2025 · 2025-12-31
| Gross margin | 71.1% |
| Operating margin | 47.6% |
| Net margin | 34.5% |
| Return on equity | 21.4% |
| Return on assets | 17.6% |
| Revenue growth (YoY) | 7.5% |
| EPS (basic) | ¥263.73 |
| EPS growth (YoY) | 12.0% |
| Current ratio | — |
| Equity ratio | 82.1% |
| Book value / share | ¥1,105.04 |
| Free cash flow | 310,007 M |